Published in J Virol on July 11, 2007
Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus. J Virol (2007) 1.96
Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosis. PLoS Pathog (2012) 1.76
Current understanding of the mechanism of HPV infection. Gynecol Oncol (2010) 1.74
Human papillomavirus type 16 entry: retrograde cell surface transport along actin-rich protrusions. PLoS Pathog (2008) 1.69
Clathrin- and caveolin-independent entry of human papillomavirus type 16--involvement of tetraspanin-enriched microdomains (TEMs). PLoS One (2008) 1.63
Target cell cyclophilins facilitate human papillomavirus type 16 infection. PLoS Pathog (2009) 1.57
Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis. PLoS Genet (2015) 1.38
Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections. PLoS Pathog (2012) 1.36
Viral entry mechanisms: human papillomavirus and a long journey from extracellular matrix to the nucleus. FEBS J (2009) 1.36
Caveolin-1-dependent infectious entry of human papillomavirus type 31 in human keratinocytes proceeds to the endosomal pathway for pH-dependent uncoating. J Virol (2008) 1.36
Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes. PLoS One (2009) 1.25
Human papillomavirus L2 facilitates viral escape from late endosomes via sorting nexin 17. Traffic (2012) 1.23
Replication and partitioning of papillomavirus genomes. Adv Virus Res (2008) 1.21
Replication and assembly of human papillomaviruses. J Dent Res (2009) 1.20
Tissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virions. J Virol (2009) 1.18
Human papillomavirus type 16 infection of human keratinocytes requires clathrin and caveolin-1 and is brefeldin a sensitive. J Virol (2009) 1.17
Papillomavirus infection requires gamma secretase. J Virol (2010) 1.12
Virus activated filopodia promote human papillomavirus type 31 uptake from the extracellular matrix. Virology (2008) 1.10
HPV16 and BPV1 infection can be blocked by the dynamin inhibitor dynasore. Am J Ther (2008) 1.08
Annexin A2 and S100A10 regulate human papillomavirus type 16 entry and intracellular trafficking in human keratinocytes. J Virol (2013) 1.08
Usage of heparan sulfate, integrins, and FAK in HPV16 infection. Virology (2010) 1.08
Dynamin- and lipid raft-dependent entry of decay-accelerating factor (DAF)-binding and non-DAF-binding coxsackieviruses into nonpolarized cells. J Virol (2009) 1.05
Mechanisms of cell entry by human papillomaviruses: an overview. Virol J (2010) 1.04
Rift Valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosis. J Virol (2012) 1.02
Human papillomavirus types 16, 18, and 31 share similar endocytic requirements for entry. J Virol (2013) 1.01
Overlapping and independent structural roles for human papillomavirus type 16 L2 conserved cysteines. Virology (2009) 1.01
Bovine papillomavirus type 1: from clathrin to caveolin. J Virol (2008) 1.01
Opposing effects of bacitracin on human papillomavirus type 16 infection: enhancement of binding and entry and inhibition of endosomal penetration. J Virol (2012) 1.01
The nuclear retention signal of HPV16 L2 protein is essential for incoming viral genome to transverse the trans-Golgi network. Virology (2014) 1.00
Cellular receptor binding and entry of human papillomavirus. Virol J (2010) 0.99
The role of NH4Cl and cysteine proteases in Human Papillomavirus type 16 infection. Virol J (2009) 0.93
Concepts of papillomavirus entry into host cells. Curr Opin Virol (2013) 0.93
Host-cell factors involved in papillomavirus entry. Med Microbiol Immunol (2012) 0.92
Differential dependence on host cell glycosaminoglycans for infection of epithelial cells by high-risk HPV types. PLoS One (2013) 0.91
Differentiation-dependent interpentameric disulfide bond stabilizes native human papillomavirus type 16. PLoS One (2011) 0.90
Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies. Future Microbiol (2010) 0.90
Binding and neutralization characteristics of a panel of monoclonal antibodies to human papillomavirus 58. J Gen Virol (2010) 0.89
Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implications. Protein Sci (2009) 0.86
The high risk HPV16 L2 minor capsid protein has multiple transport signals that mediate its nucleocytoplasmic traffic. Virology (2011) 0.85
Inoculation of young horses with bovine papillomavirus type 1 virions leads to early infection of PBMCs prior to pseudo-sarcoid formation. J Gen Virol (2011) 0.83
[HPV-associated carcinomas of the female genital tract. Molecular mechanisms of development]. Pathologe (2011) 0.83
Function of membrane rafts in viral lifecycles and host cellular response. Biochem Res Int (2011) 0.82
Infectious spleen and kidney necrosis virus (a fish iridovirus) enters Mandarin fish fry cells via caveola-dependent endocytosis. J Virol (2011) 0.80
Caveolin-1 mediated uptake via langerin restricts HIV-1 infection in human Langerhans cells. Retrovirology (2014) 0.79
Principles of polyoma- and papillomavirus uncoating. Med Microbiol Immunol (2012) 0.79
The cytoskeleton in papillomavirus infection. Viruses (2011) 0.78
Recent developments in the interactions between caveolin and pathogens. Adv Exp Med Biol (2012) 0.78
Entry of Classical Swine Fever Virus into PK-15 Cells via a pH-, Dynamin-, and Cholesterol-Dependent, Clathrin-Mediated Endocytic Pathway That Requires Rab5 and Rab7. J Virol (2016) 0.78
Novel antivirals inhibit early steps in HPV infection. Antiviral Res (2011) 0.77
Papillomavirus Infectious Pathways: A Comparison of Systems. Viruses (2015) 0.77
Coat as a dagger: the use of capsid proteins to perforate membranes during non-enveloped DNA viruses trafficking. Viruses (2014) 0.76
Real-time Imaging of Rabies Virus Entry into Living Vero cells. Sci Rep (2015) 0.76
Host cell restriction factors that limit transcription and replication of human papillomavirus. Virus Res (2016) 0.75
Molecular mechanisms of HPV mediated neoplastic progression. Infect Agent Cancer (2016) 0.75
Functional rafts in cell membranes. Nature (1997) 38.89
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst (1995) 18.86
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol (1988) 16.82
Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med (2007) 16.39
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst (2000) 14.43
Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol (2001) 8.93
Lipid domain structure of the plasma membrane revealed by patching of membrane components. J Cell Biol (1998) 8.91
Tubular membrane invaginations coated by dynamin rings are induced by GTP-gamma S in nerve terminals. Nature (1995) 7.81
Virus entry: open sesame. Cell (2006) 6.33
Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol (1993) 5.62
Dynamin-mediated internalization of caveolae. J Cell Biol (1998) 5.26
Acidification of macrophage and fibroblast endocytic vesicles in vitro. Proc Natl Acad Sci U S A (1983) 4.65
Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science (1992) 4.49
Inhibition of clathrin-coated pit assembly by an Eps15 mutant. J Cell Sci (1999) 4.36
How viruses enter animal cells. Science (2004) 4.35
Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium. J Cell Biol (1998) 3.99
Membrane microdomains and caveolae. Curr Opin Cell Biol (1999) 3.34
Human papillomavirus infection requires cell surface heparan sulfate. J Virol (2001) 3.32
Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J Cell Biol (2005) 3.26
Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol Biol Cell (1996) 3.23
Effects of cholesterol depletion by cyclodextrin on the sphingolipid microdomains of the plasma membrane. Biochem J (1998) 3.22
A functional link between dynamin and the actin cytoskeleton at podosomes. J Cell Biol (2000) 3.12
Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Virology (1996) 2.83
Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins. Biol Reprod (1997) 2.74
Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol (1997) 2.58
Papillomaviruses infect cells via a clathrin-dependent pathway. Virology (2003) 2.47
Laboratory production in vivo of infectious human papillomavirus type 11. J Virol (1987) 2.20
JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis. J Virol (2000) 2.16
Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition. J Virol (2007) 2.05
Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. J Virol (2003) 1.79
Infection of vero cells by BK virus is dependent on caveolae. J Virol (2004) 1.77
Human papillomaviruses bind a basal extracellular matrix component secreted by keratinocytes which is distinct from a membrane-associated receptor. Virology (2005) 1.73
Production of infectious human papillomavirus independently of viral replication and epithelial cell differentiation. Proc Natl Acad Sci U S A (2005) 1.72
Viral entry. Curr Top Microbiol Immunol (2005) 1.69
Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. J Virol (2006) 1.67
Invasion of host cells by JC virus identifies a novel role for caveolae in endosomal sorting of noncaveolar ligands. J Virol (2006) 1.47
Human papillomavirus type 31b infection of human keratinocytes does not require heparan sulfate. J Virol (2005) 1.44
Postattachment neutralization of papillomaviruses by monoclonal and polyclonal antibodies. Virology (1995) 1.40
Detergent extraction of cholera toxin and gangliosides from cultured cells and isolated membranes. Biochim Biophys Acta (1982) 1.39
Human papillomavirus type 31b infection of human keratinocytes and the onset of early transcription. J Virol (2002) 1.37
Kinetics of in vitro adsorption and entry of papillomavirus virions. Virology (2004) 1.37
Neutralization of animal virus infectivity by antibody. Arch Virol (2007) 1.34
Infectious human papillomavirus type 31b: purification and infection of an immortalized human keratinocyte cell line. J Gen Virol (2002) 1.23
Papillomavirus virus-like particles activate the PI3-kinase pathway via alpha-6 beta-4 integrin upon binding. Virology (2006) 1.10
Mechanisms regulating expression of the HPV 31 L1 and L2 capsid proteins and pseudovirion entry. Virol J (2007) 1.08
Papillomavirus particles assembled in 293TT cells are infectious in vivo. J Virol (2006) 1.08
Human papillomavirus type 6b virus-like particles are able to activate the Ras-MAP kinase pathway and induce cell proliferation. J Virol (2001) 0.92
The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle. J Virol (2005) 1.53
Human papillomavirus type 31b infection of human keratinocytes does not require heparan sulfate. J Virol (2005) 1.44
Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections. PLoS Pathog (2012) 1.36
Caveolin-1-dependent infectious entry of human papillomavirus type 31 in human keratinocytes proceeds to the endosomal pathway for pH-dependent uncoating. J Virol (2008) 1.36
Metabolically biotinylated adenovirus for cell targeting, ligand screening, and vector purification. Mol Ther (2003) 1.33
Sumoylation dynamics during keratinocyte differentiation. J Cell Sci (2006) 1.26
Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes. PLoS One (2009) 1.25
Human papillomavirus L2 facilitates viral escape from late endosomes via sorting nexin 17. Traffic (2012) 1.23
The development of quantum dot calibration beads and quantitative multicolor bioassays in flow cytometry and microscopy. Anal Biochem (2007) 1.22
Cellular entry of human papillomavirus type 16 involves activation of the phosphatidylinositol 3-kinase/Akt/mTOR pathway and inhibition of autophagy. J Virol (2012) 1.21
Propagation of infectious human papillomavirus type 16 by using an adenovirus and Cre/LoxP mechanism. Proc Natl Acad Sci U S A (2004) 1.15
Using an immortalized cell line to study the HPV life cycle in organotypic "raft" cultures. Methods Mol Med (2005) 1.13
A transmembrane domain and GxxxG motifs within L2 are essential for papillomavirus infection. J Virol (2012) 1.10
Virus activated filopodia promote human papillomavirus type 31 uptake from the extracellular matrix. Virology (2008) 1.10
Cryoelectron microscopy of protein IX-modified adenoviruses suggests a new position for the C terminus of protein IX. J Virol (2006) 1.09
Annexin A2 and S100A10 regulate human papillomavirus type 16 entry and intracellular trafficking in human keratinocytes. J Virol (2013) 1.08
Nitric oxide induces early viral transcription coincident with increased DNA damage and mutation rates in human papillomavirus-infected cells. Cancer Res (2009) 1.06
Variable expression of some "housekeeping" genes during human keratinocyte differentiation. Anal Biochem (2002) 1.03
Opposing effects of bacitracin on human papillomavirus type 16 infection: enhancement of binding and entry and inhibition of endosomal penetration. J Virol (2012) 1.01
Inducible heat shock protein 70 enhances HPV31 viral genome replication and virion production during the differentiation-dependent life cycle in human keratinocytes. Virus Res (2009) 0.89
Biotinylated gene therapy vectors. Expert Opin Biol Ther (2003) 0.87
Human papillomavirus type 16 does not require cathepsin L or B for infection. J Gen Virol (2013) 0.77
No evidence of a death-like function for species B1 human adenovirus type 3 E3-9K during A549 cell line infection. BMC Res Notes (2012) 0.75